GlassScriptPhysician profile
Michael Samuel Amster
NPI 1821097478
$1,773.39
in general payments reported to CMS, 2019-2025
21 companies · $348 in 2025
The $348 reported for 2025 was more than what 88% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $199 · 2021: $342 · 2022: $46.19 · 2023: $144 · 2024: $253 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $213.48 | 2019-2025 | Doc Band |
| Supernus Pharmaceuticals, INC. | $198.93 | 2022-2025 | Qelbree, Qelbree |
| Kaleo, INC. | $157.11 | 2019-2021 | |
| Pfizer INC. | $138.76 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $137.01 | 2019-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Sanofi Pasteur INC. | $125.69 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $114.05 | 2019-2021 | |
| Alk-Abello, INC | $113.02 | 2023-2025 | Grastek, Odactra, Neffy |
| Ironshore Pharmaceuticals INC. | $112.24 | 2019-2024 | |
| Nevro Corp. | $111.61 | 2019 | |
| Corium, LLC | $108.61 | 2024-2025 | Azstarys |
| Novartis Pharmaceuticals Corporation | $42.58 | 2019 | |
| Collegium Pharmaceutical, INC. | $39.01 | 2025 | Jornay Pm |
| Verrica Pharmaceuticals INC. | $32.95 | 2024 | Ycanth |
| Neos Therapeutics, LP | $27.08 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $23.58 | 2021 | |
| Shire North American Group INC | $22.66 | 2019 | |
| Tris Pharma INC | $17.79 | 2021 | |
| Adlon Therapeutics L.P. | $13.59 | 2021 | |
| Glaxosmithkline, LLC. | $12.16 | 2022 | |
| Vertical Pharmaceuticals, LLC | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Amster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.